Stocks and Investing
Stocks and Investing
Fri, January 14, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, January 13, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Arvind Ramnani Maintained (BLND) at Buy with Decreased Target to $10 on, Jan 13th, 2022
Arvind Ramnani of Piper Sandler, Maintained "Blend Labs, Inc." (BLND) at Buy with Decreased Target from $13 to $10 on, Jan 13th, 2022.
Arvind has made no other calls on BLND in the last 4 months.
There are 2 other peers that have a rating on BLND. Out of the 2 peers that are also analyzing BLND, 0 agree with Arvind's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Arvind
- Michael Turrin of "Wells Fargo" Maintained at Buy with Decreased Target to $15 on, Monday, December 13th, 2021
- Josh Beck of "Keybanc" Maintained at Buy with Decreased Target to $16 on, Friday, November 12th, 2021
Contributing Sources